These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17341059)

  • 1. 1,4-benzodiazepines as inhibitors of respiratory syncytial virus. The identification of a clinical candidate.
    Henderson EA; Alber DG; Baxter RC; Bithell SK; Budworth J; Carter MC; Chubb A; Cockerill GS; Dowdell VC; Fraser IJ; Harris RA; Keegan SJ; Kelsey RD; Lumley JA; Stables JN; Weerasekera N; Wilson LJ; Powell KL
    J Med Chem; 2007 Apr; 50(7):1685-92. PubMed ID: 17341059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,4-Benzodiazepines as inhibitors of respiratory syncytial virus.
    Carter MC; Alber DG; Baxter RC; Bithell SK; Budworth J; Chubb A; Cockerill GS; Dowdell VC; Henderson EA; Keegan SJ; Kelsey RD; Lockyer MJ; Stables JN; Wilson LJ; Powell KL
    J Med Chem; 2006 Apr; 49(7):2311-9. PubMed ID: 16570927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of a respiratory syncytial virus fusion inhibitor clinical candidate, part 1: improving the pharmacokinetic profile using the structure-property relationship.
    Bonfanti JF; Doublet F; Fortin J; Lacrampe J; Guillemont J; Muller P; Queguiner L; Arnoult E; Gevers T; Janssens P; Szel H; Willebrords R; Timmerman P; Wuyts K; Janssens F; Sommen C; Wigerinck P; Andries K
    J Med Chem; 2007 Sep; 50(19):4572-84. PubMed ID: 17722899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin.
    Xu Z; Kuang M; Okicki JR; Cramer H; Chaudhary N
    Antiviral Res; 2004 Mar; 61(3):195-206. PubMed ID: 15168801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity.
    Wang XA; Cianci CW; Yu KL; Combrink KD; Thuring JW; Zhang Y; Civiello RL; Kadow KF; Roach J; Li Z; Langley DR; Krystal M; Meanwell NA
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4592-8. PubMed ID: 17576060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121).
    Bonfanti JF; Meyer C; Doublet F; Fortin J; Muller P; Queguiner L; Gevers T; Janssens P; Szel H; Willebrords R; Timmerman P; Wuyts K; van Remoortere P; Janssens F; Wigerinck P; Andries K
    J Med Chem; 2008 Feb; 51(4):875-96. PubMed ID: 18254606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of highly potent benzodiazepine gamma-secretase inhibitors: preparation of (2S,3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement.
    Churcher I; Williams S; Kerrad S; Harrison T; Castro JL; Shearman MS; Lewis HD; Clarke EE; Wrigley JD; Beher D; Tang YS; Liu W
    J Med Chem; 2003 Jun; 46(12):2275-8. PubMed ID: 12773031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus fusion inhibitors. Part 7: structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo.
    Sin N; Venables BL; Combrink KD; Gulgeze HB; Yu KL; Civiello RL; Thuring J; Wang XA; Yang Z; Zadjura L; Marino A; Kadow KF; Cianci CW; Clarke J; Genovesi EV; Medina I; Lamb L; Krystal M; Meanwell NA
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4857-62. PubMed ID: 19596574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin.
    Li Y; But PP; Ooi VE
    Antiviral Res; 2005 Oct; 68(1):1-9. PubMed ID: 16140400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RSV604, a novel inhibitor of respiratory syncytial virus replication.
    Chapman J; Abbott E; Alber DG; Baxter RC; Bithell SK; Henderson EA; Carter MC; Chambers P; Chubb A; Cockerill GS; Collins PL; Dowdell VC; Keegan SJ; Kelsey RD; Lockyer MJ; Luongo C; Najarro P; Pickles RJ; Simmonds M; Taylor D; Tyms S; Wilson LJ; Powell KL
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3346-53. PubMed ID: 17576833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo.
    Yu KL; Wang XA; Civiello RL; Trehan AK; Pearce BC; Yin Z; Combrink KD; Gulgeze HB; Zhang Y; Kadow KF; Cianci CW; Clarke J; Genovesi EV; Medina I; Lamb L; Wyde PR; Krystal M; Meanwell NA
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1115-22. PubMed ID: 16368233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrimidine containing RSV fusion inhibitors.
    Nikitenko A; Raifeld Y; Mitsner B; Newman H
    Bioorg Med Chem Lett; 2005 Jan; 15(2):427-30. PubMed ID: 15603966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,2,3,9b-Tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 2: identification of BTA9881 as a preclinical candidate.
    Bond S; Draffan AG; Fenner JE; Lambert J; Lim CY; Lin B; Luttick A; Mitchell JP; Morton CJ; Nearn RH; Sanford V; Anderson KH; Mayes PA; Tucker SP
    Bioorg Med Chem Lett; 2015 Feb; 25(4):976-81. PubMed ID: 25595685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of daphnoretin isolated from Wikstroemia indica.
    Ho WS; Xue JY; Sun SS; Ooi VE; Li YL
    Phytother Res; 2010 May; 24(5):657-61. PubMed ID: 19610034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure and affinity of novel 3-alkoxy-1,2-dihydro-3H-1,4-benzodiazepin-2-ones for CNS central and peripheral benzodiazepine receptors.
    Andronati S; Semenishyna E; Pavlovsky V; Simonov Y; Makan S; Boyko I; Burenkova N; Gdaniec M; Cardinael P; Bouillon JP; Mazepa A
    Eur J Med Chem; 2010 Apr; 45(4):1346-51. PubMed ID: 20061068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral efficacy of VP14637 against respiratory syncytial virus in vitro and in cotton rats following delivery by small droplet aerosol.
    Wyde PR; Laquerre S; Chetty SN; Gilbert BE; Nitz TJ; Pevear DC
    Antiviral Res; 2005 Oct; 68(1):18-26. PubMed ID: 16112208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of nyasol and structurally related compounds as the active principles from Anemarrhena asphodeloides against respiratory syncytial virus (RSV).
    Bae G; Yu JR; Lee J; Chang J; Seo EK
    Chem Biodivers; 2007 Sep; 4(9):2231-5. PubMed ID: 17886842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysoxylins A-D, tetranortriterpenoids with potent anti-RSV activity from Dysoxylum gaudichaudianum.
    Chen JL; Kernan MR; Jolad SD; Stoddart CA; Bogan M; Cooper R
    J Nat Prod; 2007 Feb; 70(2):312-5. PubMed ID: 17315968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals.
    Ojwang JO; Wang YH; Wyde PR; Fischer NH; Schuehly W; Appleman JR; Hinds S; Shimasaki CD
    Antiviral Res; 2005 Dec; 68(3):163-72. PubMed ID: 16280176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent anti-respiratory syncytial virus activity of a cholestanol-sulfated tetrasaccharide conjugate.
    Lundin A; Bergström T; Andrighetti-Fröhner CR; Bendrioua L; Ferro V; Trybala E
    Antiviral Res; 2012 Jan; 93(1):101-9. PubMed ID: 22101246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.